|
業務類別
|
Biotechnology |
|
業務概覽
|
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
| 公司地址
| 325 Binney Street, Cambridge, MA, USA, 02142 |
| 電話號碼
| +1 617 714-6500 |
| 傳真號碼
| +1 617 583-1998 |
| 公司網頁
| https://www.modernatx.com |
| 員工數量
| 4700 |
| Dr. David Berman, M.D. |
Chief Development Officer |
-- |
16/03/2026 |
| Mr. Stephane Bancel |
Director and Chief Executive Officer |
美元 1.68M |
16/03/2026 |
| Mr. James M Mock |
Chief Financial Officer and Principal Accounting Officer |
美元 852.19K |
16/03/2026 |
| Dr. Stephen Hoge, M.D. |
President |
美元 1.26M |
16/03/2026 |
| Ms. Shannon Thyme Klinger |
Chief Legal Officer and Corporate Secretary |
美元 852.19K |
16/03/2026 |
| Ms. Tracey Franklin |
Chief People and Digital Technology Officer |
-- |
16/03/2026 |
| Dr. Jerh Collins, PhD |
Chief Technical Operations and Quality Officer |
-- |
16/03/2026 |
| Dr. Rose Loughlin, PhD |
Executive Vice President, Research |
-- |
16/03/2026 |
|
|
| Ms. Elizabeth E. Tallett |
Independent Director |
16/03/2026 |
| Mr. Paul Sagan |
Independent Director |
16/03/2026 |
| Dr. Noubar B. Afeyan, PhD |
Chairman of the Board |
16/03/2026 |
| Mr. Stephane Bancel |
Director and Chief Executive Officer |
16/03/2026 |
| Dr. Elizabeth G. Nabel, M.D. |
Independent Director |
16/03/2026 |
| Dr. Sandra J. Horning, M.D. |
Independent Director |
16/03/2026 |
| Mr. Abbas Hussain |
Independent Director |
16/03/2026 |
| Dr. Francois Nader, M.D. |
Independent Director |
16/03/2026 |
| Mr. David M. Rubenstein |
Independent Director |
16/03/2026 |
|
|
|
|
